STUDY QUESTION: Does second-hand smoke (SHS) exposure from husbands have adverse effects on sex hormones, metabolic profiles, clinical phenotypes and fertility outcomes in women with polycystic ovary syndrome (PCOS) undergoing ovulation induction?
Introduction
Polycystic ovary syndrome (PCOS) is the most common endocrine disorder in women of reproductive age, with a prevalence range of 5-15% (Rosenfield and Ehrmann, 2016) . It is characterized by infertility, menstrual dysfunction and hirsutism. Other manifestations include metabolic abnormalities, insulin resistance, dyslipidemia, type 2 diabetes mellitus and cardiovascular diseases (Gu et al., 2009; Pau et al., 2013) .
It is well known that smoking is associated with many diseases including infertility (Practice Committee of the American Society for Reproductive Medicine, 2012) . In women, smoking is likely to impair fecundity at some stages of the reproductive process (Dechanet et al., 2010) . It was also reported to be associated with low birth weight in pregnancies of women who smoked while undergoing assisted reproductive treatment (Tong et al., 2016) . Exposure to second-hand smoke (SHS) has been associated with an increased risk of implantation failure and lower live birth rate in infertile women undergoing ART (Benedict et al., 2011) . For women with PCOS, smoking could result in aggravated hyperandrogenism and insulin resistance, and an increased risk of metabolic syndrome (Cupisti et al., 2010; Pau et al., 2013) . However, whether a habitual smoking partner impact the reproductive parameters in women with PCOS is not known? Compared with nonsmokers, couples in whom both partners smoked had a lower chance of live birth (odds ratio (OR) = 0.20; 95% CI, 0.08-0.52), but no effect of female or male smoking alone was observed (Polotsky et al., 2015) . It is also not clear whether women with PCOS who do not smoke but are exposed to SHS from partners have any adverse effects on other pregnancy outcomes.
In China, the percentage of women exposed to SHS is almost 70%, while in the United States, it is just under 50% (Yao et al., 2012; Fischer and Kraemer, 2017) . It is therefore important to know the potential hazard of SHS exposure on endocrine, metabolism and reproduction in women with PCOS. In this study, we aimed to investigate, in women with PCOS, the influence of SHS exposure on circulating sex steroids and gonadotropins, glucose and lipid metabolism, metabolic syndrome and phenotypes (namely hirsutism, acne, oligomenorrhea, amenorrhea and polycystic ovaries), as well as fertility and obstetric outcomes.
Materials and Methods

Participants
This was a prospective observational study on SHS exposure in women with PCOS. Data were recorded in the context of the PolyCystic Ovary Syndrome Acupuncture plus Clomiphene Trial (PCOSAct) (Wu et al., 2017) . The PCOSAct was a large-sample, multi-center, randomized controlled trial which was carried out between 2012 and 2015 in mainland China. The institutional review boards at the local sites approved the protocol and all patients together with their husbands provided written informed consent before joining the study.
The trial was registered on ClinicalTrials.gov (NCT01573858) and chictr. org.cn (ChiCTR-TRC-12002081). The study protocol has been described elsewhere (Kuang et al., 2013) and the main results were published in details (Wu et al., 2017) . In brief, Chinese women suffering from anovulation related to PCOS and requesting ovulation induction were eligible. PCOS was defined by the modified Rotterdam criteria (Rotterdam, 2004) . Exclusion criteria included other endocrine disorders, use of hormonal or other medication including Chinese herbal prescriptions in the past 2 months, miscarriage or having given birth within 6 weeks, and breastfeeding within the last 6 months. For the present study, husbands with poor sperm counts (sperm concentrations <15 × 10 6 /mL, total motility <40%, semen volume ≤1.5 mL and total motile sperm count ≤9 million (Cooper et al., 2010) ) were excluded. Women who were current smokers and/or alcohol users were excluded from the present study.
SHS exposure
SHS exposure status was classified based on a self-reported questionnaire. SHS exposure was defined as regular exposure to SHS (having lived with a partner who is a chronic smoker on a daily basis) in the past 6 months (Soldin et al., 2011) . High and low exposures were further defined as a partner smoking >10 cigarettes/day and ≤10 cigarettes/day, respectively (Olivo-Marston et al., 2009). We did not assess duration of SHS per day nor assay serum nicotine or cotinine levels to determine SHS severity in this study.
Physical examination
Participating women underwent a complete physical examination at baseline including weight and height measurement, waist and hip circumferences, systolic blood pressure (SBP), diastolic blood pressure (DBP), pulse rate and transvaginal ultrasound examination of the ovaries. The BMI and waist-to-hip ratio (WHR) were calculated.
Interventions
In the PCOSAct, all participants were randomized to one of four treatments including active acupuncture plus clomiphene, control acupuncture plus clomiphene, active acupuncture plus clomiphene placebo or control acupuncture plus clomiphene placebo for four menstrual cycles. Pregnancy outcomes were assessed after each cycle. Once conception was achieved, the intervention was stopped and the pregnancy was followed up until miscarriage or delivery.
Biochemical measurements
Baseline fasting circulating sex steroids and gonadotropins and glucose and lipid metabolism measurements, including total testosterone (TT), free testosterone (FT), sex hormone binding globulin (SHBG), estradiol (E 2 ), progesterone (P), LH, FSH, fasting glucose, total fasting insulin, total cholesterol, triglyceride, lipoproteins A, high-density lipoprotein (HDL), lowdensity lipoprotein (LDL), apolipoprotein A1 (ApoA1) and apolipoprotein B (ApoB), were measured at the core laboratory in Heilongjiang University of Chinese Medicine. All sex hormones were analyzed by electrochemiluminescent immunoassays, except FT which was measured by radioimmunoassay (RIA). Glucose and lipid profiles were measured by enzymatic methods. Free androgen index (FAI), testosterone/estradiol ratio (T/E2) and the homeostasis model assessment-insulin resistance (HOMA-IR) were calculated. Husbands' semen analyses were performed in local laboratories and semen parameters were determined according to WHO 2010 criteria (World Health Organization, 2010 .
Metabolic syndrome and phenotypes
Metabolic syndrome was defined according to the ATP III criteria when three out of the five following criteria presented: waist circumference >88 cm, triglycerides ≥150 mg/dL, HDL <50 mg/dL, blood pressure ≥135/85 mmHg and fasting glucose ≥110 mg/dL (Grundy et al., 2004) . Hirsutism was scored in accordance with the modified Ferryman-Gallwey (MF-G) score. MF-G score ≥5 was classified as hirsutism in Mainland China (Zhao et al., 2011) . Biochemical hyperandrogenism was defined as an androstenedione level of >10.8 nmol/l or total testosterone ≥2.81 nmol/L . Acne was measured using a standard acne lesion assessment diagram and definitions (Tan et al., 2007) . Oligomenorrhea was defined as an intermenstrual interval >35 days and <8 menstrual bleedings in a year, and amenorrhea was defined as an intermenstrual interval >90 days (Norman et al., 2007) . Polycystic ovaries were diagnosed by transvaginal ultrasound when at least one ovary had a volume of >10 mL or there were 12 or more follicles measuring 2-9 mm in diameter (Balen et al., 2003) .
Fertility outcomes
Ovulation was defined as a serum progesterone level above 5 ng/mL during a cycle. Ovulation rates were calculated from patients who achieved one or more ovulations in four cycles. Conception was defined as any positive serum hCG test, i.e. biochemical pregnancy. Clinical pregnancy was defined as an intrauterine pregnancy with fetal heart pulsation as detected by transvaginal ultrasound. Pregnancy losses included miscarriage or fetal demises and stillbirths before and after 20 weeks, respectively. Live birth was defined as the delivery of a viable infant.
Obstetric outcomes
Obstetric outcomes, including gestational age, preterm delivery, neonatal gender, birth weight, body length, 1 and 5 Apgar scores and neonatal intensive care unit (NICU) admission rate, were recorded.
Statistical analysis
The sample size was based on the PCOSAct (Wu et al., 2017) . In 500 couples, our sample size allowed us to show a difference of 10% conception rate between non-exposed and SHS-exposed groups with Power 95% and Type I error 0.05. Data were described as frequencies and percentages for categorical data, or medians (Q1, Q3) for numerical data. Mann-Whitney test and chi-square test or Fisher's exact test were used to compare differences between the two groups. Differences and OR for pregnancy and obstetric outcomes were estimated by multivariable logistic regression with adjustment for parameters based on the significant differences in univariate analyses. Since clomiphene, but not acupuncture, increased live birth in our PCOAct, the analysis was also adjusted by clomiphene treatment only. The risks of outcomes between low or high SHS exposure and the non-exposed group were also calculated. The interaction between clomiphene and SHS was analyzed by general liner model or logistic regression. Binary logistic regression was employed to analyze whether SHS exposure is independent of ovulation and metabolic syndrome. All hypothesis tests were two-sided. A P-value < 0.05 was considered to indicate statistical significance. All statistical analyses were done using the SPSS statistical package version 22.0.
Results
Out of the 1000 women recruited in PCOSAct, all women finished the questionnaire. Yet not all couples reported their smoking status; data on SHS exposure status were available in 500 women only. We excluded the 12 women who were current smokers. Amongst 500 women, 271 were non-exposed, and 229 were exposed, of whom 59 were high-exposed and 170 were low-exposed. The baseline age, height, weight, waist, hip, pulse, SBP, DBP, BMI and WHR of the included women with PCOS and their partners' semen parameters were comparable (Table I) .
Exposed women, compared to non-exposed women, had significantly higher serum total testosterone and free androgen index and lower sex hormone binding globulin (Table II) . There was a doseresponse effect, with women in high-exposed group, but not in low-exposed group, having significantly higher total testosterone, free testosterone, free androgen index and T/E2 ratio and lower sex hormone binding globulin than those in non-exposed group.
The baseline fasting circulating glucose and insulin did not differ between the two groups. The total cholesterol, triglyceride, lipoproteins A, HDL, LDL, ApoA1 and ApoB levels were not statistically different between the exposed and non-exposed groups, nor between the high-or low-exposed and non-exposed groups (Table III) .
There were no differences in the proportion of women with hirsutism, acne, oligomenorrhea, amenorrhea and polycystic ovary morphology between the exposed and non-exposed groups, nor between the high-or low-exposed and non-exposed groups (Table IV) . The rate of metabolic syndrome was significant higher in women in exposed group than in the non-exposed. Both high-and low-exposed groups had a higher frequency of metabolic syndrome than the nonexposed group.
Amongst 500 women with PCOS, 399 had one or more ovulations (79.8%), 161 had a biochemical pregnancy (32.2%), 110 had a clinical pregnancy (22.0%), 58 had a pregnancy loss (36.0%) and 103 had a live birth (20.6%). Ovulation (OR = 6.85, 95% CI = 3.03-15.50), conception (OR = 2.72, 95% CI = 1.63-4.46), clinical pregnancy (OR = 2.36, 95% CI = 1.33-4.18) and live birth (OR = 2.26, 95% CI = 1.26-4.06) were significantly different between the clomiphene and placebo subgroups within the non-exposed group, while only ovulation (OR = 6.45, 95% CI = 3.03-13.75) and conception (OR = 2.43, 95% CI = 1.31-4.51) were significantly different within the SHS exposed group Sex hormones Non-exposed (N = 271)
LH (IU/L) 9.2 (6.0, 13.8) 9.6 (6.6, 14.4) 10.0 (6.4, 14.8) 9.0 (6.7, 13. Medians (Q1, Q3) are presented. P 1 = total exposed vs non-exposed, P 2 = low-exposed vs non-exposed, P 3 = high-exposed vs non-exposed, *P < 0.05 compared total exposed with non-exposed groups, # P < 0.05 compared high-exposed with non-exposed groups. Non-exposed (N = 271) SHS exposed (N = 229) P-value
Demographic characteristics
Age ( Medians (Q1, Q3) are presented. a = progressive motility, b = non-linear motility, c = non-progressive motility. P 1 = total exposed vs non-exposed, P 2 = low-exposed vs nonexposed, P 3 = high-exposed vs non-exposed. No significant differences between total, high or low exposed groups and non-exposed group.
(Supplementary Table SI) . SHS exposure was not significantly associated with ovulation, but was significantly associated with metabolic syndrome (Supplementary Table SII ). The ovulation rate between SHS-exposed and non-exposed groups was not significantly different. Women in the exposed group had a lower conception rate than those in the non-exposed group, while clinical pregnancy rate, and live birth rate were also lower, but the differences were not statistically significant. Both high-and low-exposed groups, compared with the nonexposed group, had lower conception rates (Table V) . There was no interaction between clomiphene and SHS exposure for all pregnancy outcomes. The gestational age, preterm birth rate, male and female rates, birth weight, body length and NICU admission between the exposed group and non-exposed group were not significantly different (Table VI) , nor were there differences between the high-or low-exposed groups and nonexposed group. None of newborns had 1 and 5 min Apgar score <5.
Discussion
We evaluated in women with PCOS the impact of SHS exposure on circulating sex steroids, glucose and lipid metabolism, metabolic syndrome and phenotypes, fertility and obstetric outcomes. We demonstrate that women exposed to SHS have higher serum total testosterone and free androgen index and lower SHBG than non-exposed women. With high-exposure, women had a higher serum TT and FT and lower SHBG and estradiol levels. Exposure to SHS is also associated with an increased risk of metabolic syndrome and lower conception rate in women with PCOS, even after adjustment for total and free testosterone, SHBG and treatments.
Our study thoroughly investigated the effect of SHS exposure on endocrine parameters, metabolic syndrome, fertility and obstetric outcomes in women with PCOS. For half the women, SHS exposure status was not available due to incomplete questionnaires and lose of contact. Although the sample size was not very large, we had similar numbers of women in the non-exposed and SHS exposed groups and the interventions were randomized. The potential selection bias might underestimate the adverse effects of SHS exposure, but we expected it to be minimal. We did not record the duration of SHS exposure per day nor quantify the serum nicotine/cotinine to validate the status of SHS exposure. In addition, the intercourse frequency may be a confounding factor to the pregnancy outcomes. Current evidence has shown that smoking could result in erectile dysfunction (Lam et al., 2006) , reduced intercourse frequency (Yamamura, 2014) and female sexual dysfunction (Choi et al., 2015) , while more frequent intercourse is associated with a greater chance of successful infertility treatment (Polotsky et al., 2015) . Therefore, apart from physical activity and dietary habits, smoking in men is likely to have lower intercourse frequency which, to some extent, has influence on pregnancy outcomes for infertile couples.
Tobacco smoke has a complex mixture containing an estimated 5000 chemicals (Borgerding and Klus, 2005) . SHS contains most of the toxic carcinogens from tobacco smoke, and nicotine is a most common and important component of SHS (Besaratinia and Pfeifer, 2008) . The ovary is the major organ of testosterone biosynthesis in women. Nicotine has been shown to inhibit aromatase activity (Nelson and Bulun, 2001) . Aromatase is a key enzyme responsible for the conversion of androgen to estrogen in ovary. In vitro, aromatase activity is inhibited directly by nicotine, and estrogen synthesis is hampered in granulosa cells exposed to high dose of nicotine (Barbieri et al., 1986; Sanders et al., 2002) . Nicotine can also block aromatase activity in female baboons in vivo (Biegon et al., 2010) . In our study, women with high SHS exposure had slightly lower estradiol levels than nonexposed (186.8 vs 194.8 pmol/L); this suggests the even high SHS exposure is still not as high as in-vitro and animal studies. The sex hormone effect of SHS exposure on the women with PCOS seems to be a dose response effect as the high-but not the low-exposed groups had altered estradiol levels. We speculate that there is a threshold effect for SHS exposure rather than dose-response effect. However, large-scale study has indicated that the elevation of testosterone is associated with the dose of exposure to tobacco smoke in postmenopausal women (Brand et al., 2011) . Unlike active smoking, serum nicotine concentrations are altered little between passive smokers and non-smokers (Pau et al., 2013) , which may in part explain the only slightly increased biochemical hyperandrogenism in the low-exposed group. Here, we were not able to analyze this association due to a lack of precise data regarding dose-exposure of SHS. Glucose and Lipid Non-exposed (N = 271) SHS exposed (N = 229) P-value
Total Medians (Q1, Q3) are presented. P 1 = total exposed vs non-exposed, P 2 = low-exposed vs non-exposed, P 3 = high-exposed vs non-exposed. No significant differences between total, high or low exposed groups and non-exposed group. n (%) are presented. Adjusted for total testosterone, free testosterone, sex hormone binding globulin and clomiphene. *P < 0.05 compared total exposed with non-exposed groups, # P < 0.05 compared low-exposed with non-exposed groups. n (%) are presented. Adjusted for total testosterone, free testosterone, sex hormone binding globulin and clomiphene. *P < 0.05 compared total exposed with non-exposed groups, # P < 0.05 compared high-exposed with non-exposed groups.
Our data suggest that smoking partners of infertile women with PCOS who seek treatment should be advised to quit smoking or at least not expose their partner to SHS. Smoking cessation has substantial short and long term health benefits for smokers of all ages. Compared with those continued smoking, there was 36% reduction in relative risk of mortality of coronary heart disease (Critchley and Capewell, 2003) and 30-50% reduced risk of lung cancer over 10 years for patients who quit (Edwards, 2004) . Stopping smoking for women can also restore the chances of pregnancy to the level of a non-smoking female, normalize testosterone levels (Fredricsson and Gilljam, 1992) and improve erectile dysfunction in men (Pourmand et al., 2004) . A major barrier to men quitting smoking during the pregnancy of partners is a lack of awareness of the adverse effects of passive smoking on the fetus (Wakefield et al., 1998) . Although education (Prochaska et al., 1993; Strecher et al., 2008) and individualized (Fiore et al., 1990) approaches can help the primary smoker to quit smoking, partner support may be needed for successfully quitting (Mermelstein and Lichtenstein, 1983) .
In summary, biochemical, but not clinical, hyperandrogenism was exaggerated, metabolic syndrome was more common and the conception rate was lower in women with PCOS who were exposed to SHS from partners. Medians (Q1, Q3) or n/N (%) are presented. NA, not available, NICU, neonatal intensive care unit. P 1 = total exposed vs non-exposed, P 2 = low-exposed vs non-exposed, P 3 = high-exposed vs non-exposed. No significant differences between total, high, or low exposed groups and non-exposed group.
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